Literature DB >> 8164017

Stroke in Fabry's disease.

R P Grewal.   

Abstract

This study was performed to characterize the frequency, clinical presentation and etiology of cerebrovascular complications in patients with Fabry's disease. Thirty-three patients (age range 6-64 years) with Fabry's disease were reviewed, eight (24%) of whom suffered cerebrovascular complications. All patients developed ischemic strokes involving small arterial vessels which occurred in equal frequency in carotid and vertebrobasilar distributions. In six of these eight patients, a stroke occurred prior to age 40 years. Stroke frequently complicates Fabry's disease and represents a significant source of morbidity in patients affected with this condition; it usually involves thrombosis of small arteries affected by the disease process.

Entities:  

Mesh:

Year:  1994        PMID: 8164017     DOI: 10.1007/bf00868342

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  6 in total

1.  Fabry disease: detection of 13-bp deletion in alpha-galactosidase A gene and its application to gene diagnosis of heterozygotes.

Authors:  S Ishii; H Sakuraba; M Shimmoto; R Minamikawa-Tachino; T Suzuki; Y Suzuki
Journal:  Ann Neurol       Date:  1991-05       Impact factor: 10.422

2.  An atypical variant of Fabry's disease with manifestations confined to the myocardium.

Authors:  W von Scheidt; C M Eng; T F Fitzmaurice; E Erdmann; G Hübner; E G Olsen; H Christomanou; R Kandolf; D F Bishop; R J Desnick
Journal:  N Engl J Med       Date:  1991-02-07       Impact factor: 91.245

3.  Magnetic resonance imaging in Fabry's disease.

Authors:  D G Menzies; I W Campbell; D M Kean
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

4.  The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency)--investigation of symptomatic and presymptomatic patients.

Authors:  S H Morgan; P Rudge; S J Smith; A M Bronstein; B E Kendall; E Holly; E P Young; M D Crawfurd; R Bannister
Journal:  Q J Med       Date:  1990-05

5.  Fabry's disease presenting with stroke.

Authors:  R P Grewal; N W Barton
Journal:  Clin Neurol Neurosurg       Date:  1992       Impact factor: 1.876

6.  Anderson-Fabry disease: a histopathological study of three cases with observations on the mechanism of production of pain.

Authors:  P Kahn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-12       Impact factor: 10.154

  6 in total
  15 in total

1.  [Fabry's disease: new therapeutic options for this lysosomal storage disorder].

Authors:  A J Grau; M Schwaninger; H H Goebel; M Beck
Journal:  Nervenarzt       Date:  2003-05-20       Impact factor: 1.214

2.  Sisters with atypical Fabry's disease with complete atrioventricular block.

Authors:  Y Doi; G Toda; K Yano
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

Review 3.  Single gene disorders causing ischaemic stroke.

Authors:  Saif S M Razvi; Ian Bone
Journal:  J Neurol       Date:  2006-06       Impact factor: 4.849

Review 4.  Stroke and Fabry disease.

Authors:  Miguel Viana-Baptista
Journal:  J Neurol       Date:  2011-10-27       Impact factor: 4.849

5.  Increased resting cerebral blood flow in adult Fabry disease: MRI arterial spin labeling study.

Authors:  Po Phyu; Aine Merwick; Indran Davagnanam; Fay Bolsover; Fatima Jichi; Claudia Wheeler-Kingshott; Xavier Golay; Deralynn Hughes; Lisa Cipolotti; Elaine Murphy; Robin H Lachmann; David John Werring
Journal:  Neurology       Date:  2018-03-21       Impact factor: 9.910

Review 6.  Inherited neurovascular diseases affecting cerebral blood vessels and smooth muscle.

Authors:  Christine Sam; Fei-Feng Li; Shu-Lin Liu
Journal:  Metab Brain Dis       Date:  2015-04-21       Impact factor: 3.584

7.  Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males.

Authors:  K D MacDermot; A Holmes; A H Miners
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

8.  The pharmacological chaperone 1-deoxygalactonojirimycin reduces tissue globotriaosylceramide levels in a mouse model of Fabry disease.

Authors:  Richie Khanna; Rebecca Soska; Yi Lun; Jessie Feng; Michelle Frascella; Brandy Young; Nastry Brignol; Lee Pellegrino; Sheela A Sitaraman; Robert J Desnick; Elfrida R Benjamin; David J Lockhart; Kenneth J Valenzano
Journal:  Mol Ther       Date:  2009-09-22       Impact factor: 11.454

Review 9.  The role of genetics in stroke.

Authors:  John Francis; Senthil Raghunathan; Pradeep Khanna
Journal:  Postgrad Med J       Date:  2007-09       Impact factor: 2.401

10.  Fabry disease in children and the effects of enzyme replacement treatment.

Authors:  Guillem Pintos-Morell; Michael Beck
Journal:  Eur J Pediatr       Date:  2009-02-26       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.